Caries Arresting Medicament Application Guidelines
Guidance on clinical indications and application of caries arresting medicaments (notably silver diamine fluoride) as a conservative treatment for active, non-symptomatic carious lesions and related dental review standards. Includes criteria for patient selection and example billing codes provided for informational purposes only.
Document revised with annual revisions noted through 10/21/2022 and last review date 01/01/2023.
Policy overview
Policy subject: Caries Arresting Medicament Application (e.g., Silver Diamine Fluoride). Payer: Anthem. Policy: Caries Arresting Medicament Application Guidelines.